Deutsche Bank’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-810
| Closed | -$79K | – | 4318 |
|
|
2022
Q1 | $79K | Sell |
810
-90
| -10% | -$11.6K | ﹤0.01% | 3667 |
|
|
2021
Q4 | $147K | Buy |
900
+45
| +5% | +$9.89K | ﹤0.01% | 3521 |
|
|
2021
Q3 | $233K | Sell |
855
-155
| -15% | -$47.4K | ﹤0.01% | 3484 |
|
|
2021
Q2 | $400K | Sell |
1,010
-81
| -7% | -$37.8K | ﹤0.01% | 3367 |
|
|
2021
Q1 | $590K | Sell |
1,091
-996
| -48% | -$620K | ﹤0.01% | 3001 |
|
|
2020
Q4 | $789K | Buy |
2,087
+134
| +7% | +$53.3K | ﹤0.01% | 2610 |
|
|
2020
Q3 | $738K | Buy |
1,953
+45
| +2% | +$19.9K | ﹤0.01% | 2395 |
|
|
2020
Q2 | $938K | Buy |
1,908
+911
| +91% | +$406K | ﹤0.01% | 2270 |
|
|
2020
Q1 | $367K | Buy |
997
+604
| +154% | +$313K | ﹤0.01% | 2639 |
|
|
2019
Q4 | $277K | Sell |
393
-184
| -32% | -$127K | ﹤0.01% | 3037 |
|
|
2019
Q3 | $370K | Buy |
577
+232
| +67% | +$184K | ﹤0.01% | 2839 |
|
|
2019
Q2 | $299K | Sell |
345
-17
| -5% | -$11.7K | ﹤0.01% | 3597 |
|
|
2019
Q1 | $208K | Sell |
362
-117
| -24% | -$48.9K | ﹤0.01% | 3983 |
|
|
2018
Q4 | $133K | Sell |
479
-2,722
| -85% | -$1.08M | ﹤0.01% | 4084 |
|
|
2018
Q3 | $1.54M | Buy |
3,201
+1,483
| +86% | +$636K | ﹤0.01% | 3017 |
|
|
2018
Q2 | $778K | Sell |
1,718
-2,520
| -59% | -$1.6M | ﹤0.01% | 3598 |
|
|
2018
Q1 | $2.49M | Buy |
4,238
+2,276
| +116% | +$1.42M | ﹤0.01% | 2714 |
|
|
2017
Q4 | $1.22M | Buy |
1,962
+1,148
| +141% | +$825K | ﹤0.01% | 3064 |
|
|
2017
Q3 | $749K | Sell |
814
-1,589
| -66% | -$1.41M | ﹤0.01% | 3192 |
|
|
2017
Q2 | $2.24M | Buy |
2,403
+1,823
| +314% | +$1.79M | ﹤0.01% | 2483 |
|
|
2017
Q1 | $550K | Sell |
580
-91
| -14% | -$84.7K | ﹤0.01% | 3030 |
|
|
2016
Q4 | $537K | Sell |
671
-4,044
| -86% | -$3.64M | ﹤0.01% | 3136 |
|
|
2016
Q3 | $3.98M | Sell |
4,715
-101
| -2% | -$81.2K | ﹤0.01% | 1893 |
|
|
2016
Q2 | $3.96M | Buy |
4,816
+4,610
| +2,238% | +$5.02M | ﹤0.01% | 1923 |
|
|
2016
Q1 | $228K | Sell |
206
-485
| -70% | -$496K | ﹤0.01% | 3598 |
|
|
2015
Q4 | $860K | Sell |
691
-373
| -35% | -$617K | ﹤0.01% | 2979 |
|
|
2015
Q3 | $1.44M | Buy |
1,064
+421
| +65% | +$695K | ﹤0.01% | 2702 |
|
|
2015
Q2 | $1.16M | Buy |
643
+176
| +38% | +$273K | ﹤0.01% | 2875 |
|
|
2015
Q1 | $752K | Buy |
467
+101
| +28% | +$150K | ﹤0.01% | 3054 |
|
|
2014
Q4 | $276K | Sell |
366
-323
| -47% | -$171K | ﹤0.01% | 4115 |
|
|
2014
Q3 | $272K | Sell |
689
-80
| -10% | -$38.6K | ﹤0.01% | 3896 |
|
|
2014
Q2 | $464K | Buy |
769
+68
| +10% | +$37.9K | ﹤0.01% | 3517 |
|
|
2014
Q1 | $481K | Buy |
701
+446
| +175% | +$299K | ﹤0.01% | 3363 |
|
|
2013
Q4 | $165K | Sell |
255
-279
| -52% | -$166K | ﹤0.01% | 3792 |
|
|
2013
Q3 | $314K | Buy |
534
+265
| +99% | +$119K | ﹤0.01% | 3828 |
|
|
2013
Q2 | $84K | Buy |
+269
| New | +$74.7K | ﹤0.01% | 4306 |
|
Other funds holding TCRT
MP
DCM
LCM
Deutsche Bank's TCRT Position: Q2 2022 in Review
Deutsche Bank sold out of Alaunos Therapeutics (TCRT) in Q2 2022, closing a stake of 810 shares — an estimated $79K sold.
Deutsche Bank first reported a position in TCRT in Q2 2013 and held it in 36 quarters. The position peaked at $3.98M in Q3 2016. 124 funds tracked by Wall St. Rank hold TCRT as of Q2 2022.
- Deutsche Bank reported no remaining Alaunos Therapeutics position as of Q2 2022 after selling out during the quarter.
- Deutsche Bank sold 810 Alaunos Therapeutics shares in Q2 2022, an estimated $79K.
- Deutsche Bank first reported a position in Alaunos Therapeutics in Q2 2013 and held it in 36 quarters.
- Deutsche Bank's Alaunos Therapeutics position peaked at $3.98M in Q3 2016.
- 124 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2022.
Based on Deutsche Bank's 13F filing for Q2 2022, filed 11 Aug 2022.